🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $EXPN.L and executed a SELL strategy, securing a +27.05% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ALCLS.PA

Cellectis SA

European UnionEUROPEAN UNION
FREE PREVIEW
AVG HISTORICAL GAP0.84%
MAX GAP RECORD0.84%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY0.8%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL